Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4buf | F36 | Tankyrase-2 | 2.4.2.30 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4buf | F36 | Tankyrase-2 | 2.4.2.30 | 1.000 | |
4bui | W2E | Tankyrase-2 | 2.4.2.30 | 0.691 | |
4hlk | 431 | Tankyrase-2 | 2.4.2.30 | 0.683 | |
4but | 31F | Tankyrase-2 | 2.4.2.30 | 0.644 | |
4buu | F38 | Tankyrase-2 | 2.4.2.30 | 0.633 | |
3kr8 | XAV | Tankyrase-2 | 2.4.2.30 | 0.621 | |
4l0s | 1UZ | Tankyrase-2 | 2.4.2.30 | 0.617 | |
4l31 | F08 | Tankyrase-2 | 2.4.2.30 | 0.615 | |
4bu9 | 08C | Tankyrase-2 | 2.4.2.30 | 0.613 | |
4bud | 29F | Tankyrase-2 | 2.4.2.30 | 0.612 | |
4l10 | A63 | Tankyrase-2 | 2.4.2.30 | 0.605 | |
4hkn | LU2 | Tankyrase-2 | 2.4.2.30 | 0.601 | |
4kzu | A73 | Tankyrase-2 | 2.4.2.30 | 0.600 | |
4j22 | AJ7 | Tankyrase-2 | 2.4.2.30 | 0.597 | |
4hkk | AGI | Tankyrase-2 | 2.4.2.30 | 0.564 | |
4l0t | 1V0 | Tankyrase-2 | 2.4.2.30 | 0.511 | |
5aku | 29F | Tankyrase-2 | 2.4.2.30 | 0.511 | |
4l34 | 1VG | Tankyrase-2 | 2.4.2.30 | 0.492 | |
4l33 | F70 | Tankyrase-2 | 2.4.2.30 | 0.490 | |
4hlg | 20B | Tankyrase-2 | 2.4.2.30 | 0.471 | |
4l0v | 1V1 | Tankyrase-2 | 2.4.2.30 | 0.466 | |
4l0i | 1UW | Tankyrase-2 | 2.4.2.30 | 0.465 | |
4l2f | 1V3 | Tankyrase-2 | 2.4.2.30 | 0.458 | |
4iue | AJ4 | Tankyrase-2 | 2.4.2.30 | 0.456 | |
4hlf | 15Z | Tankyrase-2 | 2.4.2.30 | 0.454 | |
4kzl | 20D | Tankyrase-2 | 2.4.2.30 | 0.453 | |
4bue | JQF | Tankyrase-2 | 2.4.2.30 | 0.447 | |
4l32 | 1VF | Tankyrase-2 | 2.4.2.30 | 0.443 |